-
Mashup Score: 0Over a quarter of stem cell transplant survivors develop cutaneous malignant neoplasms - 8 hour(s) ago
More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, development of chronic graft-versus-host disease and receipt of total body irradiation.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 0Living organ donors to receive $10,000 tax credit under new law - 3 month(s) ago
A new Michigan law will provide a tax credit of up to $10,000 to living organ donors. The law takes effect Jan. 1, 2025.
Source: www.wxyz.comCategories: General Medicine News, General HCPsTweet-
Our liver #transplant recipient Dave Galbenski told @wxyzdetroit he hopes a new Michigan law will double or triple the number of living organ donors: https://t.co/6RPLvOTB6C
-
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 0
After protests from transplant patient advocacy groups and legislators for more than a year, CMS has agreed to drop a proposal that would have limited access to a noninvasive test used to determine the health of a transplanted organ.“Organ transplant patients depend on these blood tests to know whether their transplant is successful,” Rep. Anna Eshoo, D-Calif., said in a press
Source: www.healio.comCategories: General Medicine News, NephrologyTweet-
.@CMSGov 🏨🏦 ends plans to limit use of test for evaluating #transplant graft health 🧮. Patient advocacy groups and legislators pressed the agency to reverse its initial decision ▪️▪️ 🏥. https://t.co/rZ3NR6jDM1
-
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 1
A shared passion for patient care inspires blood and bone marrow transplant and cellular therapy innovation at Ohio State.
Source: cancer.osu.eduCategories: General Medicine News, Onc News and JournalsTweet-
A shared passion for patient care inspires blood and bone marrow #transplant and cellular therapy innovation @OhioState. https://t.co/TNwc76AcZg
-
-
Mashup Score: 33
Clinical Transplantation is an international transplantation journal publishing the latest research surrounding organ and tissue transplant surgery.
Source: onlinelibrary.wiley.comCategories: General Medicine News, GastroenterologyTweet-
Important work by @serperm et al on a virtual program for alcohol use disorder for high-risk patients undergoing liver #transplant evaluation! >70% completion rate 10% rate of sustained alcohol use, No deaths or graft dysfunction (2+ yrs of followup) https://t.co/nNwLHDrsr0 https://t.co/I2zbpNDR61
-
Over 25% of blood or marrow transplant survivors may develop cutaneous malignant neoplasms, according to data in @JAMADerm. Healio spoke with an assistant professor at @UABNews about the retrospective cohort study and its data. #Transplant @UABSurgery https://t.co/2dtLbVUd3i